| Invested through |
|
|---|---|
| Asset Classes | Listed equity |
| Impact strategy | Impact Equities and Bonds |
| Bloomberg ticker | GN DC |
| ISIN code | DK0010272632 |
| Industry group | Health Care Equipment |
| Aligned with SDGs |
GN Store Nord develops, manufactures, and markets medical, professional, and consumer audio solutions. The company operates through GN Hearing and GN Audio segments. The GN Hearing segment produces and sells hearing instruments and products for people with hearing loss. The GN Audio segment supplies headsets and speakerphone solutions primarily for professional use (one example are Jabra speakers), and consumer headsets and earbuds for calls, music, and media consumption. GN has central manufacturing sites in China, Malaysia and Denmark. GN's hearing aids are sold in more than 100 countries, supported by direct operations in 30 countries and partnerships in another 70. GN Store Nord was founded in 1869 and is headquartered in Ballerup, Denmark.
Investment rationale
GN Store Nord is one of the leading manufacturers of hearing aid devices. By providing hearing aid products, the company helps people with impaired hearing overcome their health challenges. The company also offers other audio equipment for professional and recreational use. Thus GN contributes to increasing productivity in the workplace and helps people increase their fitness with its wireless headsets for mobile users that allow an active lifestyle. With its strategic focus on innovation, aiming to make life sound better, GN sponsors external acoustic and hearing research.
Alignment with Triodos Transitions:
In total 39% of the revenues of the company is aligned with the Wellbeing Transition. The contribution to the Wellbeing transition comes from 39% of revenues related to the impact objective Healthcare.